Medtronic plc (BVMF:MDTC34)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of BRL 650.82 billion. The enterprise value is 760.49 billion.

Market Cap	650.82B
Enterprise Value	760.49B

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	Sep 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.52%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	87.65%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 25.16 and the forward PE ratio is 16.71.

PE Ratio	25.16
Forward PE	16.71
PS Ratio	3.43
PB Ratio	2.44
P/TBV Ratio	n/a
P/FCF Ratio	22.11
P/OCF Ratio	16.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.74, with an EV/FCF ratio of 25.84.

EV / Earnings	29.40
EV / Sales	4.20
EV / EBITDA	14.74
EV / EBIT	21.74
EV / FCF	25.84

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.59.

Current Ratio	2.01
Quick Ratio	1.25
Debt / Equity	0.59
Debt / EBITDA	2.94
Debt / FCF	5.39
Interest Coverage	8.95

Financial Efficiency

Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 5.40%.

Return on Equity (ROE)	9.74%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	5.40%
Return on Capital Employed (ROCE)	8.31%
Revenue Per Employee	2.00M
Profits Per Employee	272,242
Employee Count	95,000
Asset Turnover	0.38
Inventory Turnover	2.10

Taxes

In the past 12 months, Medtronic has paid 5.39 billion in taxes.

Income Tax	5.39B
Effective Tax Rate	17.15%

Stock Price Statistics

The stock price has decreased by -1.32% in the last 52 weeks. The beta is 0.74, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-1.32%
50-Day Moving Average	247.47
200-Day Moving Average	235.35
Relative Strength Index (RSI)	52.16
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.08

Income Statement

In the last 12 months, Medtronic had revenue of BRL 189.81 billion and earned 25.86 billion in profits. Earnings per share was 20.10.

Revenue	189.81B
Gross Profit	124.10B
Operating Income	36.66B
Pretax Income	31.42B
Net Income	25.86B
EBITDA	52.43B
EBIT	36.66B
Earnings Per Share (EPS)	20.10

Balance Sheet

The company has 45.07 billion in cash and 158.78 billion in debt, giving a net cash position of -113.60 billion.

Cash & Cash Equivalents	45.07B
Total Debt	158.78B
Net Cash	-113.60B
Net Cash Per Share	n/a
Equity (Book Value)	267.14B
Book Value Per Share	207.36
Working Capital	64.90B

Cash Flow

In the last 12 months, operating cash flow was 39.66 billion and capital expenditures -10.23 billion, giving a free cash flow of 29.43 billion.

Operating Cash Flow	39.66B
Capital Expenditures	-10.23B
Free Cash Flow	29.43B
FCF Per Share	n/a

Margins

Gross margin is 65.38%, with operating and profit margins of 19.31% and 13.63%.

Gross Margin	65.38%
Operating Margin	19.31%
Pretax Margin	16.55%
Profit Margin	13.63%
EBITDA Margin	27.62%
EBIT Margin	19.31%
FCF Margin	15.51%

Dividends & Yields

This stock pays an annual dividend of 5.85, which amounts to a dividend yield of 2.39%.

Dividend Per Share	5.85
Dividend Yield	2.39%
Dividend Growth (YoY)	9.62%
Years of Dividend Growth	1
Payout Ratio	77.27%
Buyback Yield	2.52%
Shareholder Yield	4.91%
Earnings Yield	3.97%
FCF Yield	4.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.82 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.82
Piotroski F-Score	6